Related Experiment Video
Updated: May 2, 2026

Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a
David Soave1, Melissa R Miller2, Katherine Keenan3
1Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, CanadaDivision of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Insights
Lower newborn immunoreactive trypsinogen (IRT) levels in cystic fibrosis (CF) predict higher risk for CF-related diabetes (CFRD). Early detection may allow interventions to delay CFRD onset.
Area of Science:
- Endocrinology
- Genetics
- Pediatrics
Background:
- Circulating immunoreactive trypsinogen (IRT) is a biomarker for exocrine pancreatic disease in cystic fibrosis (CF).
- IRT levels in newborns with severe CFTR genotypes typically decline rapidly, indicating progressive pancreatic damage.
- A less elevated newborn IRT may correlate with more severe pancreatic disease and increased risk of CF-related diabetes (CFRD).
Purpose of the Study:
- To investigate the association between newborn IRT levels and the risk of developing CFRD in individuals with severe CFTR genotypes.
- To explore a potential causal relationship between exocrine pancreatic function and CFRD risk.
Main Methods:
- Analysis of two independent CF cohorts to assess the relationship between newborn IRT and CFRD risk.
- Utilizing Mendelian randomization with the SLC26A9 rs7512462 genotype as an instrumental variable for IRT levels.
Main Results:
- A lower newborn IRT estimate was significantly associated with a higher risk of CFRD in individuals with severe CFTR genotypes.
- Increased loge(IRT) at birth showed an inverse association with CFRD risk in both Canadian and Colorado CF samples.
- Mendelian randomization provided evidence supporting a causal link between exocrine pancreatic status and CFRD risk.
Conclusions:
- Newborn IRT levels can potentially predict CFRD risk in early life for individuals with CF.
- Maintaining ductal fluid flow in the exocrine pancreas may be a strategy to delay CFRD onset.
- These findings highlight the intricate relationship between exocrine and endocrine pancreatic function in CF.
Abstract:
Circulating immunoreactive trypsinogen (IRT), a biomarker of exocrine pancreatic disease in cystic fibrosis (CF), is elevated in most CF newborns. In those with severe CF transmembrane conductance regulator (CFTR) genotypes, IRT declines rapidly in the first years of life, reflecting progressive pancreatic damage. Consistent with this progression, a less elevated newborn IRT measure would reflect more severe pancreatic disease, including compromised islet compartments, and potentially increased risk of CF-related diabetes (CFRD). We show in two independent CF populations that a lower newborn IRT estimate is associated with higher CFRD risk among individuals with severe CFTR genotypes, and we provide evidence to support a causal relationship. Increased loge(IRT) at birth was associated with decreased CFRD risk in Canadian and Colorado samples (hazard ratio 0.30 [95% CI 0.15-0.61] and 0.39 [0.18-0.81], respectively). Using Mendelian randomization with the SLC26A9 rs7512462 genotype as an instrumental variable since it is known to be associated with IRT birth levels in the CF population, we provide evidence to support a causal contribution of exocrine pancreatic status on CFRD risk. Our findings suggest CFRD risk could be predicted in early life and that maintained ductal fluid flow in the exocrine pancreas could delay the onset of CFRD.
More Related Videos
07:44Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation
Published on: August 7, 2015
07:39A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals
Published on: June 25, 2018
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Type I Diabetes II: Pathophysiology
Type I Diabetes I: Introduction